Drug-eluting stent

Stents Market Revenue to Cross USD 14 Bn by 2026: Global Market Insights, Inc.

Retrieved on: 
Tuesday, January 19, 2021
Interventional cardiology, Interventional radiology, Stent, Medical technology, Medicine, Medical equipment, Drug-eluting stent

SELBYVILLE, Del., Jan. 19, 2021 /PRNewswire/ --According to latest report "Stents Market by Product (Vascular Stents, Non-vascular Stents), Material (Metal, Polymer), Type, (Self-expandable Stents, Balloon-expandable Stents), End-use (Hospitals, Ambulatory Surgical Centers), Regional Outlook, Price Trends, Competitive Market Share & Forecast 2026", by Global Market Insights, Inc., the market valuation of stents will cross $14.3 billion by 2026.

Key Points: 
  • SELBYVILLE, Del., Jan. 19, 2021 /PRNewswire/ --According to latest report "Stents Market by Product (Vascular Stents, Non-vascular Stents), Material (Metal, Polymer), Type, (Self-expandable Stents, Balloon-expandable Stents), End-use (Hospitals, Ambulatory Surgical Centers), Regional Outlook, Price Trends, Competitive Market Share & Forecast 2026", by Global Market Insights, Inc., the market valuation of stents will cross $14.3 billion by 2026.
  • Rigorous RD activities by the manufacturers to develop innovative stents will be one of the key factors driving the stents market demand.
  • Polymer stent segment in the stents market is forecasted to reach USD 3 billion by 2026.
  • Self-expandable stents segment accounted for 36.1% of the market share in 2019 and is expected to exceed USD 5.3 billion by 2026.

Elixir Medical Announces First Patient Treated in BIOADAPTOR Randomized Controlled Trial of DynamX Coronary Bioadaptor System

Retrieved on: 
Wednesday, January 13, 2021
Medical devices, Health, Surgery, Clinical trials, General Health, Cardiology, Medicine, Clinical medicine, Medical specialties, Interventional cardiology, Medical devices, Interventional radiology, Percutaneous coronary intervention, Everolimus, Drug-eluting stent, Stent, Revascularization, Coronary stent

Elixir Medical , a developer of innovative, drug-eluting cardiovascular devices, today announced that the first patient has been treated in the BIOADAPTOR randomized controlled trial (RCT) of the DynamX Coronary Bioadaptor System , the first drug-eluting coronary artery implant that adapts to vessel physiology.

Key Points: 
  • Elixir Medical , a developer of innovative, drug-eluting cardiovascular devices, today announced that the first patient has been treated in the BIOADAPTOR randomized controlled trial (RCT) of the DynamX Coronary Bioadaptor System , the first drug-eluting coronary artery implant that adapts to vessel physiology.
  • We are enthusiastic about leading this trial studying an important innovation in percutaneous coronary interventions, the bioadaptor, said Dr. Saito.
  • The DynamX Bioadaptor RCT is an important contribution to demonstrating the significant benefits our device offers for patients, said Motasim Sirhan, Elixir Medical CEO.
  • Final 5-Year Follow-Up of a Randomized Controlled Trial of Everolimus- and Paclitaxel-Eluting Stents for Coronary Revascularization in Daily Practice.

Peripheral Stent Implants Market to Close in on US$ 6 Bn by 2030, Driven by Increasing Peripheral Artery Disease Patient Pool Worldwide - Persistence Market Research

Retrieved on: 
Tuesday, January 12, 2021
Interventional radiology, Medical specialties, Medical devices, Medicine, Medical technology, Interventional cardiology, Stent, Steroid eluting sinus stent, Drug-eluting stent, Restenosis

Further, rising adoption of vascular stenting procedures is also surging demand for peripheral stents, propelling the growth of the global peripheral stent implants market.

Key Points: 
  • Further, rising adoption of vascular stenting procedures is also surging demand for peripheral stents, propelling the growth of the global peripheral stent implants market.
  • The global peripheral stent implants market is expected to exhibit a healthy CAGR of nearly 7% over the forecast period (20202030).
  • Higher peripheral artery disease patient pool and increasing adoption of peripheral vascular stents in Asian countries are expected to propel market growth in the region.
  • Get Full Access of Report: https://www.persistencemarketresearch.com/checkout/32225
    Manufactures in the peripheral stent implants market are actively focusing on launching new products to hold a better position in the peripheral stent implants market.

Peripheral Stent Implants Market to Close in on US$ 6 Bn by 2030, Driven by Increasing Peripheral Artery Disease Patient Pool Worldwide - Persistence Market Research

Retrieved on: 
Tuesday, January 12, 2021
Interventional radiology, Medical specialties, Medical devices, Medicine, Medical technology, Interventional cardiology, Stent, Steroid eluting sinus stent, Drug-eluting stent, Restenosis

Further, rising adoption of vascular stenting procedures is also surging demand for peripheral stents, propelling the growth of the global peripheral stent implants market.

Key Points: 
  • Further, rising adoption of vascular stenting procedures is also surging demand for peripheral stents, propelling the growth of the global peripheral stent implants market.
  • The global peripheral stent implants market is expected to exhibit a healthy CAGR of nearly 7% over the forecast period (20202030).
  • Higher peripheral artery disease patient pool and increasing adoption of peripheral vascular stents in Asian countries are expected to propel market growth in the region.
  • Get Full Access of Report: https://www.persistencemarketresearch.com/checkout/32225
    Manufactures in the peripheral stent implants market are actively focusing on launching new products to hold a better position in the peripheral stent implants market.

Marizyme Announces the Use of DuraGraft® as the Standard-of-Care in Patients Undergoing Coronary Artery Bypass Surgery (CABG) at Vienna Heart Center North Floridsdorf

Retrieved on: 
Monday, January 11, 2021
Clinical medicine, Medicine, Cardiac surgery, Medical specialties, Coronary artery bypass surgery, Minimally invasive cardiac surgery, Drug-eluting stent

Vienna Heart Center North Floridsdorf, an internationally recognized leader, is Austria's latest super-specialty center.

Key Points: 
  • Vienna Heart Center North Floridsdorf, an internationally recognized leader, is Austria's latest super-specialty center.
  • The hospital has a Heart and Vascular Center with a focus on aortic procedures and minimally invasive cardiovascular procedures and all techniques of CABG.
  • "We have seen encouraging evidence that reinforces the importance of appropriate graft treatment during surgery and the role of DuraGraft in significantly improving outcomes in all patients.
  • Additionally, we have observed significant myocardial protection utilizing DuraGraft during CABG, where we have implemented a recent study," said Associate Professor Priv.

Marizyme Announces the Use of DuraGraft® as the Standard-of-Care in Patients Undergoing Coronary Artery Bypass Surgery (CABG) at Vienna Heart Center North Floridsdorf

Retrieved on: 
Monday, January 11, 2021
Clinical medicine, Medicine, Cardiac surgery, Medical specialties, Coronary artery bypass surgery, Minimally invasive cardiac surgery, Drug-eluting stent

Vienna Heart Center North Floridsdorf, an internationally recognized leader, is Austria's latest super-specialty center.

Key Points: 
  • Vienna Heart Center North Floridsdorf, an internationally recognized leader, is Austria's latest super-specialty center.
  • The hospital has a Heart and Vascular Center with a focus on aortic procedures and minimally invasive cardiovascular procedures and all techniques of CABG.
  • "We have seen encouraging evidence that reinforces the importance of appropriate graft treatment during surgery and the role of DuraGraft in significantly improving outcomes in all patients.
  • Additionally, we have observed significant myocardial protection utilizing DuraGraft during CABG, where we have implemented a recent study," said Associate Professor Priv.

2020 Global Drug-Eluting Stents Market Analysis, by Product, Application, End User and Region

Retrieved on: 
Wednesday, December 23, 2020
Interventional cardiology, Drug-eluting stent, Medical technology, Medicine, Stent, Medical equipment, Phosphorylcholine, Biosensors International

DUBLIN, Dec. 23, 2020 /PRNewswire/ -- The "Global Drug-Eluting Stents Market" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Dec. 23, 2020 /PRNewswire/ -- The "Global Drug-Eluting Stents Market" report has been added to ResearchAndMarkets.com's offering.
  • The report also includes market projections through 2024 and the market rank for key market players.
  • The report details the market share of drug-eluting stents based on types of products, applications and end-user.
  • By product type, the market is segmented into polymer-based drug-eluting stents and polymer-free drug-eluting stents.

Worldwide Implantable Drug Delivery Devices Market to 2027 - Opportunity Analysis and Industry Forecast - ResearchAndMarkets.com

Retrieved on: 
Friday, December 18, 2020
Pharmaceutical, Health, Medical devices, Medicine, Clinical medicine, Medical technology, Biomedical engineering, Implant, Prosthetics, Tissue engineering, Drug-eluting stent, Brachytherapy, Birth control

The "Implantable Drug Delivery Devices Market by Material, Product Type and End User: Global Opportunity Analysis and Industry Forecast, 2019-2027" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Implantable Drug Delivery Devices Market by Material, Product Type and End User: Global Opportunity Analysis and Industry Forecast, 2019-2027" report has been added to ResearchAndMarkets.com's offering.
  • Implantable drug delivery devices consist of a drug reservoir surrounded by a polymer or a drug polymer mixture.
  • Growth of the implantable drug delivery devices market is driven by The rise in prevalence of chronic diseases across the globe, increase in demand for minimally invasive drug delivery devices, and unwanted pregnancies over a period.
  • On the basis of product type, implantable drug eluting stents, implantable contraceptive drug delivery devices, implantable intraocular drug delivery devices, implantable brachytherapy seeds devices, and implantable drug delivery pump devices.

Global Biliary Stents Markets Report 2020

Retrieved on: 
Tuesday, November 24, 2020
Interventional cardiology, Medicine, Medical devices, Medical technology, Interventional radiology, Stent, Clinical medicine, Bioresorbable stent, Drug-eluting stent, Bare-metal stent

DUBLIN, Nov. 24, 2020 /PRNewswire/ -- The "Global Biliary Stents Markets" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Nov. 24, 2020 /PRNewswire/ -- The "Global Biliary Stents Markets" report has been added to ResearchAndMarkets.com's offering.
  • The market for biliary stents referred to in the report is limited to the devices/products included in this report.
  • Biliary stents such as metal stents, plastic stents, and biodegradable stents that are specialized for diseases or patient conditions represent some of the key opportunity areas that hold moderate growth potential for the future growth of the market for biliary stents.
  • The development of advanced metal stents, bioabsorbable stents, magnetic stents, and anti-reflux stents will drive the market during the forecast period.

Global Biliary Stents Markets Report 2020 with Profiles of Abbott, Boston Scientific, Medtronic, Edward Lifesciences, CONMED and Changzhou Health Microport Medical Devices - ResearchAndMarkets.com

Retrieved on: 
Tuesday, November 17, 2020
Medical devices, Health, Interventional cardiology, Medicine, Interventional radiology, Stent, Medical technology, Bioresorbable stent, Clinical medicine, Drug-eluting stent

Different products have different competitive scenarios in the global market for biliary stents, which is fragmented yet consolidated.

Key Points: 
  • Different products have different competitive scenarios in the global market for biliary stents, which is fragmented yet consolidated.
  • The development of advanced metal stents, bioabsorbable stents, magnetic stents, and anti-reflux stents will drive the market during the forecast period.
  • The market for biliary stents is a highly competitive market involving many public as well as regional and local companies.
  • The report also provides a detailed competitive outlook, including the market share and company profiles of the key participants operating in the global market.